Erasmus School of Health Policy & Management
Researcher | Health Services Management & Organisation (HSMO)
- l.m.devries@eshpm.eur.nl
More information
Work
- Linda M. de Vries, Werner B.F. Brouwer & Pieter H.M. van Baal (2024) - Benefits beyond health in the willingness to pay for a quality-adjusted life-year - European Journal of Health Economics - doi: 10.1007/s10198-024-01726-7 - [link]
- Linda de Vries (2024) - Reconsidering the scope of cost-effectiveness analyses in healthcare: Views on what and how costs and benefits should be included in economic evaluations of healthcare interventions
- Hamraz Mokri, Ingelin Kvamme, Linda de Vries, Matthijs Versteegh & Pieter van Baal (2023) - Future medical and non-medical costs and their impact on the cost-effectiveness of life-prolonging interventions: a comparison of five European countries - European Journal of Health Economics, 24 (5), 701-715 - doi: 10.1007/s10198-022-01501-6 - [link]
- Linda De Vries, Marion Koopmans, Alec Morton & Pieter Van Baal (2021) - The economics of improving global infectious disease surveillance - BMJ Global Health, 6 (9) - doi: 10.1136/bmjgh-2021-006597 - [link]
- L.M. de Vries, K M Kellerborg, W B F Brouwer & P H M van Baal (2021) - Don't forget about the future: The impact of including future costs on the cost-effectiveness of adult pneumococcal conjugate vaccination with PCV13 in the Netherlands - Vaccine, 39 (29), 3834-3843 - doi: 10.1016/j.vaccine.2021.05.091 - [link]
- Klas Kellerborg, Meg Perry-Duxbury, Linda de Vries & Pieter van Baal (2020) - Practical Guidance for Including Future Costs in Economic Evaluations in the Netherlands: Introducing and Applying PAID 3.0 - Value in Health - doi: 10.1016/j.jval.2020.07.004 - [link]
- Linda de Vries, Pieter van Baal & Werner Brouwer (2018) - Future Costs in Cost-Effectiveness Analyses: Past. Present, Future - Pharmacoeconomics (Online) - doi: 10.1007/s40273-018-0749-8 - [link]
